FYI... 8/5 Post: chartwise, .1935 would indicate a

New Post Public Reply Private Reply Replies (1) Message Board
joey68 fourthjohn #172
190
FYI...
8/5 Post:
Quote:
chartwise, .1935 would indicate a reversal

.258 would confirm it

.393 would prove it


https://investorshangout.com/post/view?id=4686804


.. we broke .1935 today. Using all the knowledge i have in charting, youre correct.. this actually should be the reversal.

Now, we need .258 for confirmation.

https://xrpcharts.ripple.com/#/markets/XRP/US...;type=line
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 41

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 56

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 40

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 43

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 33

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 65

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

CompoSecure's Adam Lowe Executes $490K Stock Sale and Insights

Updated Category News Views 302

Adam Lowe's Notable Stock Transactions Revealed Adam Lowe, the Chief Product & Innovation Officer at CompoSecure, Inc. (NASDAQ: CMPO), has recently stirred up some buzz following his stock sales, which amounted to over $490,000. According to recent regulatory filings, on a pivotal day, Lowe sold 40,658 shares of CompoSecure's Class A Common Stock, netting him $490,335...

Continue Reading
Extendicare Reports Strong Q4 and Year-End Results with Dividend Boost

Updated Category News Views 299

Extendicare's Positive Financial Performance in Q4 2024 Extendicare Inc. (TSX: EXE) has released its results for the last quarter of 2024, showcasing significant growth and a successful year overall. The company, known for its commitment to quality care for seniors across Canada, reported a remarkable increase in adjusted EBITDA, a key indicator of financial performance,...

Continue Reading
The Kayon's New Villas: Ubud's Intimate Luxury Retreat

Updated Category News Views 10

Embracing Exclusive Escapes in Ubud A couple of days ago, The Kayon Resort decided to stir the pot in Ubud's luxury accommodation landscape by rolling out two swanky villa categories: the Premier Pool Villa and the Royal Jacuzzi Pool Villa. No pandering here, just straight-up elegance mingling with nature. Why Ubud's Going Gaga Over Privacy People are craving privacy and...

Continue Reading
Exploring the Vibrant Growth of the Outdoor Backpacks Market

Updated Category News Views 147

The Outdoor Backpacks Market Growth Story The Outdoor Backpacks Market is experiencing remarkable growth, expected to increase by USD 997.1 million between 2025 and 2029. This growth reflects a projected CAGR of approximately 5.4%, driven primarily by rising interest in hiking among millennials. Today's outdoor enthusiasts are not just looking for gear; they desire...

Continue Reading
Nuveen Closed-End Funds Share Updated Distribution Notices

Updated Category News Views 79

Nuveen stirred the pot back in 2024 with a fresh drop on their closed-end funds (CEFs), rolling out distribution notices that laid bare the guts of their quarterly payouts. Yeah, those notices were packed with juicy details about where investors' cash was coming from—like net investment income and capital gains—but they also signaled some unsettling shifts lurking...

Continue Reading